SCHEMBL14700377

SCHEMBL14700377

CCCc1cc(N)cc(C(=O)O)c1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.58
TDP1 Q9NUW8 4/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
GABRP O00591 4/20 0.42
GABRD O14764 4/20 0.42
GABRA1 P14867 4/20 0.42
GABRB1 P18505 4/20 0.42
GABRG2 P18507 4/20 0.42
GABRB3 P28472 4/20 0.42
GABRA5 P31644 4/20 0.42
GABRA3 P34903 4/20 0.42
GABRA2 P47869 4/20 0.42
GABRB2 P47870 4/20 0.42
GABRA4 P48169 4/20 0.42
GABRE P78334 4/20 0.42
GABRA6 Q16445 4/20 0.42
GABRG1 Q8N1C3 4/20 0.42
GABRG3 Q99928 4/20 0.42
GABRQ Q9UN88 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2926460 0.83 TDP1 (0.47) KDM4ETDP1MEN1KMT2AGABRP
SCHEMBL2806484 0.79 KDM4E (0.79) KDM4ETDP1MEN1KMT2AGABRP
SCHEMBL1931833 0.77 MAPT (0.52) KDM4ETDP1MEN1KMT2AGABRP
SCHEMBL2808086 0.77 KDM4E (0.76) KDM4ETDP1MEN1KMT2AGABRP
SCHEMBL13981267 0.75 ALDH1A1 (0.36) KDM4EALDH1A1MAPTCASP7HSD17B10
SCHEMBL2806720 0.75 TDP1 (0.61) KDM4ETDP1MEN1KMT2AGABRP
SCHEMBL2806722 0.75 TDP1 (0.61) KDM4ETDP1MEN1KMT2AGABRP
SCHEMBL2809942 0.74 KDM4E (1.00) KDM4ETDP1MEN1KMT2AGABRP
SCHEMBL90325 0.74 KDM4E (0.70) KDM4ETDP1MEN1KMT2AGABRP
SCHEMBL540821 0.74 KDM4E (0.39) KDM4ETDP1MEN1KMT2AGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910275-B1 COMPOUNDS AND THEIR SALTS SPECIFIC TO THE PPAR RECEPTORS AND THE EGF RECEPTORS AND THEIR USE IN THE MEDICAL FIELD NOGRA PHARMA LTD (IE) 2013-02-13 EP disclosed